Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 5.0% in a Single Session

Circuit Event and Unfilled Supply

The stock hit its lower circuit limit of 5.0%, the maximum daily loss allowed under its 5% price band, closing at Rs 902.15 after touching an intraday high of Rs 924.90. This price band restricts the daily downside, but the exchange floor effectively froze trading as sellers overwhelmed demand. The total traded volume was 0.2302 lakh shares, with a turnover of Rs 2.10 crore, indicating that while some trades executed, a significant portion of supply remained unfilled. This unfilled supply is typical of lower circuit events, especially in micro-cap stocks like Venus Remedies Ltd, where liquidity constraints exacerbate exit difficulties. Venus Remedies Ltd’s market capitalisation stands at Rs 1,268 crore, placing it firmly in the micro-cap segment where such circuit locks pose heightened risks for sellers.

Delivery and Volume Analysis

Delivery volumes on 24 Apr surged by 121.03% compared to the 5-day average, reaching 74,340 shares. On a lower circuit day, rising delivery volume is a critical indicator: it reflects genuine liquidation by holders rather than speculative short-selling. This suggests that shareholders are offloading actual holdings, signalling capitulation or forced selling rather than intraday trading activity. Despite the total traded volume being relatively low on the circuit day, the elevated delivery volume confirms that the selling pressure is substantive and not merely technical. Venus Remedies Ltd’s delivery data thus points to a meaningful exit of stock from existing holders — does this capitulation mark a near-term bottom or could further selling lie ahead?

Intraday Price Action

The stock opened at Rs 924.90, already down 4.34% from the previous close, and steadily declined to the lower circuit price of Rs 902.15, marking a 5.0% intraday fall. The weighted average price was closer to the low, indicating that most volume traded near the circuit floor rather than higher levels. This steady descent rather than a sharp gap-down suggests persistent selling pressure throughout the session, with no significant buyer interest emerging at intermediate price points. The intraday range of Rs 22.75 (from high to low) reflects the full extent of the permitted price band, with the circuit breaker ultimately halting further decline. Does this gradual slide into the circuit floor indicate exhaustion or a prelude to continued weakness?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day and 20-day moving averages, signalling short-term weakness. However, it remains above the 50-day, 100-day, and 200-day moving averages, suggesting that longer-term trend support has not yet been decisively broken. This mixed moving average configuration indicates that while recent momentum is negative, the stock has not fully capitulated on a longer timeframe. The current lower circuit event may therefore represent an acceleration of short-term selling pressure rather than a complete trend reversal. Does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

As a micro-cap stock with a market capitalisation of Rs 1,268 crore, Venus Remedies Ltd faces amplified liquidity risks at the lower circuit. The stock’s liquidity allows a trade size of approximately Rs 0.14 crore based on 2% of the 5-day average traded value, which is modest. On a day when the price is locked at the lower circuit, sellers face significant exit friction as buyers remain absent. This creates a scenario where sellers queue up but cannot transact, potentially leading to multi-day circuit locks if selling pressure persists. The micro-cap status compounds this risk, as fewer market participants and thinner order books limit price discovery and trade execution. With unfilled sell orders at Rs 902.15 and near-zero liquidity, how deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, which has gained 2.32% on the day, contrasting with the stock’s 5.0% loss. This divergence underscores that the decline is stock-specific rather than sector-driven. The company’s recent three-day losing streak has resulted in a cumulative fall of 14.26%, reflecting sustained selling pressure. While the broader sector and Sensex posted gains of 2.45% and 0.59% respectively, Venus Remedies Ltd underperformed significantly, highlighting the isolated nature of the sell-off.

Conclusion: Severity and Liquidity Caveats

The lower circuit lock at a 5.0% loss, combined with rising delivery volumes, confirms that genuine holders are offloading shares rather than speculative shorts driving the move. The intraday price action shows a steady decline into the circuit floor, with no meaningful buyer support emerging. Although the stock remains above longer-term moving averages, the short-term technical picture is weak. The micro-cap status and limited liquidity exacerbate exit risks, as sellers face difficulty in executing trades at these levels. This scenario raises concerns about potential multi-day circuit locks if selling pressure continues unabated — after a 5.0% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today